학술논문
1123P - A phase I study of the CDK4/6 inhibitor, palbociclib in combination with cetuximab and intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN); A result of dose escalation cohort
Document Type
Abstract
Author
Source
In Annals of Oncology October 2019 30 Supplement 5:v456-v456
Subject
Language
ISSN
0923-7534